Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jukka Westermarck

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Cell|July 17, 2007
CIP2A inhibits PP2A in human malignanciesMelissa R Junttila, Pietri Puustinen, Minna Niemelä, et al.
International Journal of Cancer|October 6, 2018
Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomideTor-Christian Johannessen, Md Mahdi Hasan-Olive, Huaiyang Zhu, et al.
Plos One|April 22, 2016
CIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes InfectionChristophe Côme, Anna Cvrljevic, Mohd Moin Khan, et al.
Cancer Research|June 19, 2021
CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer TumorigenesisAnni Laine, Srikar G Nagelli, Caroline Farrington, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Activation of PP2A-B56α leads to aberrant EGFR signaling and proliferative phenotypes in PDACClaire M Pfeffer, Sydney J Clifford, Saadia A Karim, et al.
Cell Reports|July 3, 2026
Complex I drives glutamine-dependent TCA cycle to support viability of MYC<sup>high</sup> breast cancer cellsJohanna M Anttila, Mariel Savelius, Linda Id, et al.
Cell|May 18, 2021
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancerStephin J Vervoort, Sarah A Welsh, Jennifer R Devlin, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Cell|July 17, 2007
CIP2A inhibits PP2A in human malignanciesMelissa R Junttila, Pietri Puustinen, Minna Niemelä, et al.
International Journal of Cancer|October 6, 2018
Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomideTor-Christian Johannessen, Md Mahdi Hasan-Olive, Huaiyang Zhu, et al.
Plos One|April 22, 2016
CIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes InfectionChristophe Côme, Anna Cvrljevic, Mohd Moin Khan, et al.
Cancer Research|June 19, 2021
CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer TumorigenesisAnni Laine, Srikar G Nagelli, Caroline Farrington, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Activation of PP2A-B56α leads to aberrant EGFR signaling and proliferative phenotypes in PDACClaire M Pfeffer, Sydney J Clifford, Saadia A Karim, et al.
Cell Reports|July 3, 2026
Complex I drives glutamine-dependent TCA cycle to support viability of MYC<sup>high</sup> breast cancer cellsJohanna M Anttila, Mariel Savelius, Linda Id, et al.
Cell|May 18, 2021
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancerStephin J Vervoort, Sarah A Welsh, Jennifer R Devlin, et al.
Pageof 10